IgA1 has characteristic hinge regions between the CH1 and CH2 domains (CH, the constant regions of the heavy chain), which contain at least six serine (Ser) or threonine (Thr) residues as Haemophilus influenza, the mesangial IgA immunofluorescence intensities were significantly reduced. of kidney function. Continuous exposure to circulating immune complexes made up of aberrantly glycosylated IgA1 and sequential immune response seems to be essential in the disease progression of IgAN. Removal of mesangial IgA deposition may be a challenging, but fundamental approach in the treatment of IgAN. 1. Introduction Since IgA nephropathy (IgAN) was firstly explained by Berger and Hinglais in 1968 [1], IgAN is regarded one of the most common forms of glomerulonephritis worldwide [2]. Because 30 to 40% of IgAN patients reach end-stage kidney disease within 20 years [2, Bleomycin sulfate 3], it is critical to clarify the true pathogenesis. Clinical onset of IgAN is probably more common in the second and third decades of life [4C7]. This disease is usually more common in men, but reported male-female ratios were ranging from less than 2?:?1 in Japan to as high as 6?:?1 in the United States and northern Europe. Although IgAN occurs in all ethnic groups, the reason why whites and Asians are more prone to IgAN than are blacks remains unclear [8, 9]. Approximately 50% of newly diagnosed glomerulonephritis in Japan is due to IgAN, though much lower rates are reported in the United States and Western Europe [3]. Although there seems to be true racial differences due to a genetic predisposition to IgAN, the differences in kidney biopsy practices may Bleomycin sulfate also reflect these disparities [10]. IgAN is usually characterized by predominant or codominant IgA deposits in the glomerular mesangium, but many other diseases including Henoch-Sch?nlein purpura nephritis (HSPN) are also associated with glomerular IgA deposits [10]. Now, IgAN and HSPN are recognized to be related diseases since both can be encountered consecutively in the same patient, are found in identical twins, and bear identical pathological and biological abnormalities [10]. Recent studies strongly suggest that aberrant glycosylation of the study by Suzuki et al. supported this hypothesis [27]. They exhibited the C1GalT1 Bleomycin sulfate activity was significantly lower, while the ST6GalNAc2 activity was significantly higher in EBV-immortalized IgA-secreting lymphocytes from patients with IgAN. Indeed, a more recent analysis showed that the specific haplotype combinations in C1GalT1 and ST6GalNAc2 were well associated with a predisposition for IgAN and renal outcomes [28]. However, it remains controversial whether the undergalactosylation of IgA1 is usually a direct result of functional changes in C1GALT1/Cosmc or ST6GalNAc2 activities [14]. In addition to the two glycosyltransferase genes, numerous genes such as 6.5-cM region, study demonstrated that the circulating immune complexes containing galactose-deficient IgA1 prepared from sera of IgAN patients stimulated mesangial cell proliferation more efficiently than uncomplexed IgA1 or immune complexes prepared from healthy Rabbit polyclonal to VCL control subjects [13]. This stimulatory activity was lost in fractions devoid of IgA1. Indeed, circulating immune complexes made up of higher Bleomycin sulfate levels of galactose-deficient IgA1 enhanced mesangial cell proliferation more efficiently than complexes with lower levels of galactose-deficient IgA1 [13]. Another recent study, using subcloned EBV-immortalized B cells from IgAN patients and healthy controls, revealed that the elevation in serum levels of antibodies against galactose-deficient IgA1 is usually well associated with the development of IgAN [41]. These findings strongly suggest that circulating immune complexes made up of aberrantly glycosylated Bleomycin sulfate IgA1, by accumulating in glomerular mesangium in patients with IgAN, may play pivotal functions in the development and progression of kidney injury as shown in Physique 1. Further investigations concerning the roles of these antibodies are expected to provide new insights into the pathogenesis of IgAN. Open in a separate window Physique 1 The galactose-deficient IgA1 molecule and the immune complexes formation in the pathogenesis of IgAN. IgA1 has characteristic hinge regions between the CH1 and CH2 domains (CH, the constant regions of the heavy chain), which contain at least six serine (Ser) or threonine (Thr) residues as Haemophilus influenza, the mesangial IgA immunofluorescence intensities were significantly reduced. This treatment strategy, targeting the removal of mesangial IgA1 deposits, is novel and interesting; however, we have to overcome some limitations of this study for clinical application in human IgAN. First,.